BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23097297)

  • 1. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.
    Ho L; Ferruzzi MG; Janle EM; Wang J; Gong B; Chen TY; Lobo J; Cooper B; Wu QL; Talcott ST; Percival SS; Simon JE; Pasinetti GM
    FASEB J; 2013 Feb; 27(2):769-81. PubMed ID: 23097297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease.
    Wang J; Ho L; Zhao Z; Seror I; Humala N; Dickstein DL; Thiyagarajan M; Percival SS; Talcott ST; Pasinetti GM
    FASEB J; 2006 Nov; 20(13):2313-20. PubMed ID: 17077308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration.
    Ho L; Chen LH; Wang J; Zhao W; Talcott ST; Ono K; Teplow D; Humala N; Cheng A; Percival SS; Ferruzzi M; Janle E; Dickstein DL; Pasinetti GM
    J Alzheimers Dis; 2009; 16(1):59-72. PubMed ID: 19158422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pine Bark Polyphenolic Extract Attenuates Amyloid-β and Tau Misfolding in a Model System of Alzheimer's Disease Neuropathology.
    Ono K; Zhao D; Wu Q; Simon J; Wang J; Radu A; Pasinetti GM
    J Alzheimers Dis; 2020; 73(4):1597-1606. PubMed ID: 31958081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment.
    Wang J; Ferruzzi MG; Ho L; Blount J; Janle EM; Gong B; Pan Y; Gowda GA; Raftery D; Arrieta-Cruz I; Sharma V; Cooper B; Lobo J; Simon JE; Zhang C; Cheng A; Qian X; Ono K; Teplow DB; Pavlides C; Dixon RA; Pasinetti GM
    J Neurosci; 2012 Apr; 32(15):5144-50. PubMed ID: 22496560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization.
    Wang D; Ho L; Faith J; Ono K; Janle EM; Lachcik PJ; Cooper BR; Jannasch AH; D'Arcy BR; Williams BA; Ferruzzi MG; Levine S; Zhao W; Dubner L; Pasinetti GM
    Mol Nutr Food Res; 2015 Jun; 59(6):1025-40. PubMed ID: 25689033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin-3-O-Glucuronide Alleviates Cognitive Deficit and Toxicity in Aβ
    Xu M; Huang H; Mo X; Zhu Y; Chen X; Li X; Peng X; Xu Z; Chen L; Rong S; Yang W; Liu S; Liu L
    Mol Nutr Food Res; 2021 Mar; 65(6):e2000660. PubMed ID: 33141510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of p53 up-regulated modulator of apoptosis by JNK/c-Jun pathway in β-amyloid-induced neuron death.
    Akhter R; Sanphui P; Das H; Saha P; Biswas SC
    J Neurochem; 2015 Sep; 134(6):1091-103. PubMed ID: 25891762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Nrf2 signaling by sitagliptin and quercetin combination against β-amyloid induced Alzheimer's disease in rats.
    Li Y; Tian Q; Li Z; Dang M; Lin Y; Hou X
    Drug Dev Res; 2019 Sep; 80(6):837-845. PubMed ID: 31301179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of white wine polyphenols-enriched diet on Alzheimer's disease-like pathology.
    Mendes D; Oliveira MM; Moreira PI; Coutinho J; Nunes FM; Pereira DM; Valentão P; Andrade PB; Videira RA
    J Nutr Biochem; 2018 May; 55():165-177. PubMed ID: 29525608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer's Disease Model Mice.
    Ramasamy VS; Samidurai M; Park HJ; Wang M; Park RY; Yu SY; Kang HK; Hong S; Choi WS; Lee YY; Kim HS; Jo J
    Mol Neurobiol; 2020 Jan; 57(1):315-330. PubMed ID: 31332763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
    Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: experimental approaches and clinical implications.
    Pasinetti GM
    Planta Med; 2012 Oct; 78(15):1614-9. PubMed ID: 23023952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel small molecule PT109 with multi-targeted effects against Alzheimer's disease in vitro and in vivo.
    Chen Q; Tu Y; Mak S; Chen J; Lu J; Chen C; Yang X; Wang S; Wen S; Ma S; Li M; Han Y; Wah-Keung Tsim K; Pi R
    Eur J Pharmacol; 2020 Sep; 883():173361. PubMed ID: 32673674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
    Dobarro M; Gerenu G; Ramírez MJ
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
    Regitz C; Dußling LM; Wenzel U
    Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel application of brain-targeting polyphenol compounds in sleep deprivation-induced cognitive dysfunction.
    Zhao W; Wang J; Bi W; Ferruzzi M; Yemul S; Freire D; Mazzola P; Ho L; Dubner L; Pasinetti GM
    Neurochem Int; 2015 Oct; 89():191-7. PubMed ID: 26235983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for brain accessibility and analysis of stability of selected flavonoids in relation to neuroprotection in vitro.
    Pogačnik L; Pirc K; Palmela I; Skrt M; Kim KS; Brites D; Brito MA; Ulrih NP; Silva RF
    Brain Res; 2016 Nov; 1651():17-26. PubMed ID: 27639810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.